1. Li, Weiquan, Meng, Xiangui, Yuan, Hongwei, Xiao, Wen, Zhang, Xiaoping. 2022. M2-polarization-related CNTNAP1 gene might be a novel immunotherapeutic target and biomarker for clear cell renal cell carcinoma. In IUBMB life, 74, 391-407. doi:10.1002/iub.2596. https://pubmed.ncbi.nlm.nih.gov/35023290/
2. Hengel, Holger, Magee, Alex, Mahanjah, Muhammad, Sharkia, Rajech, Schöls, Ludger. 2017. CNTNAP1 mutations cause CNS hypomyelination and neuropathy with or without arthrogryposis. In Neurology. Genetics, 3, e144. doi:10.1212/NXG.0000000000000144. https://pubmed.ncbi.nlm.nih.gov/28374019/
3. Mehta, Paulomi, Küspert, Melanie, Bale, Tejus, Piao, Xianhua, Agrawal, Pankaj B. 2017. Novel mutation in CNTNAP1 results in congenital hypomyelinating neuropathy. In Muscle & nerve, 55, 761-765. doi:10.1002/mus.25416. https://pubmed.ncbi.nlm.nih.gov/27668699/